Skip to content

Latest News & Analysis Page 181

Latest News

UK Stock News

GSK’s Blenrep Secures FDA Approval

GSK plc (LON: GSK) announced a significant victory with the US Food and Drug Administration (FDA) approving Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for…

Stay ahead of the markets

Sign up to our free Morning Markets email, every weekday before the open.